BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines.

Foster, Mitchell; Hill, Philip C; Setiabudiawan, Todia Pediatama; Koeken, Valerie A C M; Alisjahbana, Bachti; van Crevel, Reinout

Foster, Mitchell; Hill, Philip C; Setiabudiawan, Todia Pediatama; Koeken, Valerie A C M; Alisjahbana, Bachti; van Crevel, Reinout.

Affiliation

Foster M; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand.
Setiabudiawan TP; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
Koeken VACM; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
Alisjahbana B; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between The Helmholtz-Centre for Infection Research (HZI) and The Hannover Medical School (MHH), Hannover, Germany.
van Crevel R; Tuberculosis Working Group, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.

Immunol Rev ; 301(1): 122-144, 2021 05.

Article in En | MEDLINE | ID: mdl-33709421

Subject(s)
Key words

BCG; epigenetics; innate immunity; phenotypes; tuberculosis; vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Tuberculosis Vaccines / Mycobacterium tuberculosis Limits: Humans Language: En Journal: Immunol Rev Year: 2021 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google